Microfluidics Systems Are Designed for Flow-Chemistry Experiments
The Dolomite Flow Chemistry Systems from Dolomite Microfluidics can be configured to suit applications including process optimization and scale-up.
Image courtesy of Dolomite Microfluidics
The flexible Dolomite Flow Chemistry Systems from Dolomite Microfluidics can be configured to suit different applications. The systems can be used in education, continuous large-scale reactions, process optimization, scale-up, and multi-step reactions.
The Dolomite Flow Chemistry Systems are designed to provide control of residence time, reaction temperature, stoichiometry, and reagent introduction for performing detailed flow-chemistry experiments. The systems include a choice of glass microreactors or tube reactors in polytetrafluoroethylene or stainless steel from 2.5 µl up to 16 ml. The TCU-125 Temperature Controller ensures accurate temperature control of chips from 1 to 125 °C, and the tube reactors can be heated from room temperatures to 250 °C using a hotplate. The high performance and robust Mitos Duo syringe pumps ensure smooth flow rates, from 1.0 µl/min to 10 ml/min, and allow use of the two syringes independently or in one continuous flow, up to 6 bar. Standard systems can be upgraded for additional functionality, such as reaction automation, continuous work-up, small volume sample injection, or pressurized inputs.
Source: Dolomite Microfluidics
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
